Bijelic Radojka, Milicevic Snjezana, Balaban Jagoda
Health Center, Banja Luka, Bosnia and Herzegovina.
Urology Clinic, Clinical Center of Banja Luka, Bosnia and Herzegovina.
Med Arch. 2014 Oct;68(5):335-8. doi: 10.5455/medarh.2014.68.335-338. Epub 2014 Oct 15.
Clinical researches have shown an increased bone disintegration and lower bone mass in patients with calcium urolithiasis.
The goal of our research was to establish the incidence of osteoporosis in adult patients with calcium urolithiasis, on the basis of measuring mineral bone density, using DEXA method, with a special reflection on age subgroups.
Clinical research was prospective and it was implemented at the University Clinical Center of Banja Luka, at the Clinic for Endocrinology, Diabetes and Metabolic Diseases and at the Urology Clinic. Material in this research consisted of patients divided in two groups, a working and a control group. One hundred and twenty (120) patients were included in both these groups, divided in three age subgroups: 20-40, 40-60 and over 60. The working group consisted of the patients with calcium urolithiasis and the control group consisted of patients without calcium urolithiasis. Establishing of mineral bone density at L2-L4 of lumbal spine vertebrae and hip was done for the patients in both these groups, using DEXA method.
Analysis of mineral bone density using DEXA method in patients in age groups of working and control groups, as well as in the total sample of working and control groups, have shown that the patients of the working group, over 60, had a decreased mineral bone density (30% of osteopenia and 15% osteoporosis) significantly more expressed when compared to the other two age groups (12.5% in the subgroup 20-40 and 17.5% in the subgroup 40-60), which presents a statistically significant difference (p<0.05). In the control group, when taking into account age groups, osteopenia and osteoporosis were marked in 37.5% and 2.5% in the group of patients over 60, whereas in the youngest population, 5% of osteopenia was found, which presents a statistically significant difference (p<0.05). When observing the total sample of working and control group, there was a statistically significant difference in the working and control group (p<0.01); incidence of osteoporosis in the working group amounted to 7.5% and in the control group it was 0.8%.
Urolithiasis and osteoporosis are two multifactorial diseases which are evidently reciprocal. This is why we suggest that educating the population about the risk factors for occurrence of these diseases as well as preventive measures that may contribute to their decrease should begin as early as possible.
临床研究表明,钙结石患者的骨质分解增加,骨量降低。
我们研究的目的是通过使用双能X线吸收法(DEXA)测量骨矿物质密度,特别关注年龄亚组,确定成年钙结石患者骨质疏松症的发病率。
临床研究是前瞻性的,在巴尼亚卢卡大学临床中心、内分泌、糖尿病和代谢疾病诊所及泌尿外科诊所进行。本研究的材料包括分为两组的患者,即工作组和对照组。这两组各纳入120名患者,分为三个年龄亚组:20 - 40岁、40 - 60岁和60岁以上。工作组由钙结石患者组成,对照组由无钙结石患者组成。使用DEXA方法对两组患者的腰椎L2 - L4和髋部进行骨矿物质密度测定。
使用DEXA方法对工作组和对照组各年龄组患者以及工作组和对照组的总样本进行骨矿物质密度分析,结果显示,60岁以上的工作组患者骨矿物质密度降低(骨质减少30%,骨质疏松15%),与其他两个年龄组相比(20 - 40岁亚组为12.5%,40 - 60岁亚组为17.5%)更为明显,差异具有统计学意义(p<0.05)。在对照组中,考虑到年龄组,60岁以上患者组中骨质减少和骨质疏松分别为37.5%和2.5%,而在最年轻人群中,发现5%的骨质减少,差异具有统计学意义(p<0.05)。观察工作组和对照组的总样本时,工作组和对照组之间存在统计学显著差异(p<0.01);工作组骨质疏松症的发病率为7.5%,对照组为0.8%。
尿石症和骨质疏松症是两种多因素疾病,显然相互关联。这就是为什么我们建议尽早开始对公众进行关于这些疾病发生风险因素以及可能有助于降低其发病率的预防措施的教育。